GlassScriptPhysician profile
Andrew Baxter
NPI 1124346481
$10,911.96
in general payments reported to CMS, 2019-2025
32 companies · $3,095 in 2025
The $3,095 reported for 2025 was more than what 78% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,438 · 2020: $1,220 · 2021: $954 · 2022: $1,399 · 2023: $675 · 2024: $2,131 · 2025: $3,095.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,660 · Long Term Medical Supply Or Device Loan: $2,317 · Travel and Lodging: $924.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,659.94 |
| Long Term Medical Supply Or Device Loan | $2,316.67 |
| Travel and Lodging | $923.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $2,357.32 | 2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Inari Medical, INC. | $1,553.77 | 2019-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cook Medical LLC | $1,144.00 | 2019-2025 | Zilver Ptx, Rosen, Zilver Vena |
| Silk Road Medical, INC. | $1,123.66 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Janssen Pharmaceuticals, INC | $796.86 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $754.13 | 2020-2025 | Eliquis |
| Endologix LLC | $631.30 | 2022-2025 | Afx2 Bifurcated Endograft System, Alto Abdominal Stent Graft System, Endocross Device |
| Philips North America LLC | $571.51 | 2019-2022 | |
| Medtronic USA, INC. | $473.84 | 2020 | |
| Boston Scientific Corporation | $428.66 | 2021-2025 | Enroute Transcarotid Neuroprotection System |
| Tactile Systems Technology INC | $133.29 | 2019-2024 | Entre Plus, Flexitouch Plus |
| Pfizer INC. | $120.98 | 2019-2025 | |
| Medtronic, INC. | $119.03 | 2021-2024 | Ellipsys Vascular Access System |
| Medtronic Vascular, INC. | $90.18 | 2019-2020 | |
| Cardiovascular Systems INC. | $73.70 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Veryan Medical Incorporated | $59.21 | 2021 | |
| Smith+Nephew, INC. | $51.65 | 2019-2022 | |
| Asahi Intecc USA, INC. | $49.85 | 2025 | Asahi Peripheral Vascular Wires |
| Penumbra, INC. | $46.58 | 2022-2025 | Penumbra System |
| Lemaitre Vascular, INC. | $45.86 | 2022-2023 | Restoreflow |
| Stryker Corporation | $45.53 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Kci USA, INC. | $37.99 | 2019 | |
| Davol INC. | $37.04 | 2025 | Arista |
| Solventum Corporation | $28.27 | 2024-2025 | Promogran Prisma, Activ.A.C., Prevena |
| Abbott Laboratories | $24.77 | 2025 | Esprit |
| Teleflex LLC | $19.55 | 2021 | |
| Bard Peripheral Vascular, INC. | $18.08 | 2019 | |
| Haemonetics Corporation | $16.91 | 2023 | Teg6s Hemostasis System |
| Reprise Biomedical, INC. | $15.91 | 2023 | Miro3d, Miroderm |
| Biocompatibles, INC. | $15.64 | 2019 | |
| Cordis US Corp. | $13.70 | 2023 | Exoseal |
| Integra Lifesciences Corporation | $13.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Baxter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.